A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases

A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases

With the Delta variant currently fueling a resurgence of new infections in the fully vaccinated population, developing an effective therapeutic drug is especially critical and urgent in fighting COVID-19. In contrast to the many efforts to repurpose existing drugs or address only one aspect of COVI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhizhen Li, Jianping Wu, Ji Zhou, Baoshi Yuan, Jiqiao Chen, Wanchen Wu, Lian Mo, Zhipeng Qu, Fei Zhou, Yingying Dong, Kai Huang, Zhiwei Liu, Tao Wang, Deebie Symmes, Jingliang Gu, Eiketsu Sho, Jingping Zhang, Ruihuan Chen, Ying Xu
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/6c3529ada1aa4bd78d4bef494a632d38
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/6c3529ada1aa4bd78d4bef494a632d38

Ejemplares similares